Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data
Evidence of whether people living with HIV are at elevated risk of adverse COVID-19 outcomes is inconclusive. We aimed to investigate this association using the population-based National COVID Cohort Collaborative (N3C) data in the USA. We included all adult (aged ≥18 years) COVID-19 cases with any...
Saved in:
Published in | The lancet HIV Vol. 8; no. 11; p. e690 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
01.11.2021
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Evidence of whether people living with HIV are at elevated risk of adverse COVID-19 outcomes is inconclusive. We aimed to investigate this association using the population-based National COVID Cohort Collaborative (N3C) data in the USA.
We included all adult (aged ≥18 years) COVID-19 cases with any health-care encounter from 54 clinical sites in the USA, with data being deposited into the N3C. The outcomes were COVID-19 disease severity, hospitalisation, and mortality. Encounters in the same health-care system beginning on or after January 1, 2018, were also included to provide information about pre-existing health conditions (eg, comorbidities). Logistic regression models were employed to estimate the association of HIV infection and HIV markers (CD4 cell count, viral load) with hospitalisation, mortality, and clinical severity of COVID-19 (multinomial). The models were initially adjusted for demographic characteristics, then subsequently adjusted for smoking, obesity, and a broad range of comorbidities. Interaction terms were added to assess moderation effects by demographic characteristics.
In the harmonised N3C data release set from Jan 1, 2020, to May 8, 2021, there were 1 436 622 adult COVID-19 cases, of these, 13 170 individuals had HIV infection. A total of 26 130 COVID-19 related deaths occurred, with 445 among people with HIV. After adjusting for all the covariates, people with HIV had higher odds of COVID-19 death (adjusted odds ratio 1·29, 95% CI 1·16-1·44) and hospitalisation (1·20, 1·15-1·26), but lower odds of mild or moderate COVID-19 (0·61, 0·59-0·64) than people without HIV. Interaction terms revealed that the elevated odds were higher among older age groups, male, Black, African American, Hispanic, or Latinx adults. A lower CD4 cell count (<200 cells per μL) was associated with all the adverse COVID-19 outcomes, while viral suppression was only associated with reduced hospitalisation.
Given the COVID-19 pandemic's exacerbating effects on health inequities, public health and clinical communities must strengthen services and support to prevent aggravated COVID-19 outcomes among people with HIV, particularly for those with pronounced immunodeficiency.
National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. |
---|---|
AbstractList | Evidence of whether people living with HIV are at elevated risk of adverse COVID-19 outcomes is inconclusive. We aimed to investigate this association using the population-based National COVID Cohort Collaborative (N3C) data in the USA.
We included all adult (aged ≥18 years) COVID-19 cases with any health-care encounter from 54 clinical sites in the USA, with data being deposited into the N3C. The outcomes were COVID-19 disease severity, hospitalisation, and mortality. Encounters in the same health-care system beginning on or after January 1, 2018, were also included to provide information about pre-existing health conditions (eg, comorbidities). Logistic regression models were employed to estimate the association of HIV infection and HIV markers (CD4 cell count, viral load) with hospitalisation, mortality, and clinical severity of COVID-19 (multinomial). The models were initially adjusted for demographic characteristics, then subsequently adjusted for smoking, obesity, and a broad range of comorbidities. Interaction terms were added to assess moderation effects by demographic characteristics.
In the harmonised N3C data release set from Jan 1, 2020, to May 8, 2021, there were 1 436 622 adult COVID-19 cases, of these, 13 170 individuals had HIV infection. A total of 26 130 COVID-19 related deaths occurred, with 445 among people with HIV. After adjusting for all the covariates, people with HIV had higher odds of COVID-19 death (adjusted odds ratio 1·29, 95% CI 1·16-1·44) and hospitalisation (1·20, 1·15-1·26), but lower odds of mild or moderate COVID-19 (0·61, 0·59-0·64) than people without HIV. Interaction terms revealed that the elevated odds were higher among older age groups, male, Black, African American, Hispanic, or Latinx adults. A lower CD4 cell count (<200 cells per μL) was associated with all the adverse COVID-19 outcomes, while viral suppression was only associated with reduced hospitalisation.
Given the COVID-19 pandemic's exacerbating effects on health inequities, public health and clinical communities must strengthen services and support to prevent aggravated COVID-19 outcomes among people with HIV, particularly for those with pronounced immunodeficiency.
National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. |
Author | Patel, Rena C Kirk, Gregory D Olex, Amy L Li, Xiaoming Olatosi, Bankole Chute, Christopher G Weissman, Sharon B Zheng, Qulu Zhang, Jiajia Yang, Xueying Haendel, Melissa Sun, Jing Guo, Siyuan Islam, Jessica Y |
Author_xml | – sequence: 1 givenname: Xueying surname: Yang fullname: Yang, Xueying email: xueyyang@mailbox.sc.edu organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA. Electronic address: xueyyang@mailbox.sc.edu – sequence: 2 givenname: Jing surname: Sun fullname: Sun, Jing organization: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 3 givenname: Rena C surname: Patel fullname: Patel, Rena C organization: Department of Medicine, University of Washington, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA – sequence: 4 givenname: Jiajia surname: Zhang fullname: Zhang, Jiajia organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA – sequence: 5 givenname: Siyuan surname: Guo fullname: Guo, Siyuan organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA – sequence: 6 givenname: Qulu surname: Zheng fullname: Zheng, Qulu organization: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 7 givenname: Amy L surname: Olex fullname: Olex, Amy L organization: Wright Center for Clinical and Translational Research, Virginia Commonwealth University, Richmond, VA, USA – sequence: 8 givenname: Bankole surname: Olatosi fullname: Olatosi, Bankole organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA – sequence: 9 givenname: Sharon B surname: Weissman fullname: Weissman, Sharon B organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA – sequence: 10 givenname: Jessica Y surname: Islam fullname: Islam, Jessica Y organization: Center for Immunization and Infection in Cancer, Cancer Epidemiology Program, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA – sequence: 11 givenname: Christopher G surname: Chute fullname: Chute, Christopher G organization: Schools of Medicine, Public Health, and Nursing, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 12 givenname: Melissa surname: Haendel fullname: Haendel, Melissa organization: Center for Health AI, University of Colorado Anschutz Medical Campus, Aurora, CO, USA – sequence: 13 givenname: Gregory D surname: Kirk fullname: Kirk, Gregory D organization: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – sequence: 14 givenname: Xiaoming surname: Li fullname: Li, Xiaoming organization: South Carolina SmartState Center for Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Department of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA; Big Data Health Science Center, University of South Carolina, Columbia, SC, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34655550$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtOwzAQRS0EoqX0E0CzbBcBP-IQs6vCo5WqdgHttrKdiQhykyhOi_ovfCymPGZzpTNzz2IuyGlVV0jIFaM3jLLk1nMheSQoS0ecjSnlQkXihPT_cY8MvX-nlDIZpzLm56Qn4kSGoX3yOfG-tqXuyrryYLD7QKxgOltDWRVovzHoKgfryqq02oFvAm13W6gLyJbr2UPE1D1oaOpm544acLhHF1raHXwZpNpjDoGvXmBxvAiaYxWy-q1uuxDOaVO3YblHGC1ENoZcd_qSnBXaeRz-5oCsnh5fs2k0Xz7Pssk8sjKVXcRFionJecJNTKUVVhVGWCNTgZhIZWPFY50riRyNYakSTCHVKr-TKjGmUHxArn-8zc5sMd80bbnV7WHz9yb-BUB0a90 |
CitedBy_id | crossref_primary_10_1016_j_jinf_2024_01_009 crossref_primary_10_1097_QAI_0000000000003177 crossref_primary_10_1186_s12967_024_05147_1 crossref_primary_10_1016_j_jiph_2023_02_008 crossref_primary_10_1186_s12879_023_07982_x crossref_primary_10_3389_fimmu_2022_864838 crossref_primary_10_1016_j_ijid_2023_09_015 crossref_primary_10_1097_COH_0000000000000794 crossref_primary_10_7189_jogh_12_05036 crossref_primary_10_1097_QAD_0000000000003393 crossref_primary_10_1001_jamanetworkopen_2022_15934 crossref_primary_10_1093_ofid_ofac171 crossref_primary_10_3390_jcm11030700 crossref_primary_10_3390_v14040748 crossref_primary_10_2174_1570162X20666220823110435 crossref_primary_10_1093_cid_ciab1008 crossref_primary_10_1002_gch2_202300163 crossref_primary_10_1093_qjmed_hcac215 crossref_primary_10_1111_joim_13481 crossref_primary_10_3390_v15020577 crossref_primary_10_1097_QCO_0000000000000898 crossref_primary_10_3390_vaccines11010082 crossref_primary_10_7759_cureus_34688 crossref_primary_10_1016_j_isci_2023_108673 crossref_primary_10_1111_add_16105 crossref_primary_10_1007_s10096_023_04701_x crossref_primary_10_1016_S2352_3018_21_00272_1 crossref_primary_10_3390_epidemiologia3020023 crossref_primary_10_1097_CM9_0000000000002505 crossref_primary_10_1093_infdis_jiad544 crossref_primary_10_1097_QAI_0000000000002989 crossref_primary_10_3390_v15010175 crossref_primary_10_1016_S2214_109X_21_00593_3 crossref_primary_10_1093_oxfimm_iqac005 crossref_primary_10_1097_QAD_0000000000003579 crossref_primary_10_2196_47079 crossref_primary_10_3389_fmed_2024_1322440 crossref_primary_10_1097_QAI_0000000000003315 crossref_primary_10_1111_hiv_13620 crossref_primary_10_1016_j_ijid_2022_05_055 crossref_primary_10_1016_j_idc_2022_01_006 crossref_primary_10_1038_s43856_023_00245_5 crossref_primary_10_1016_j_ajem_2022_02_050 crossref_primary_10_1016_j_ijid_2022_11_035 crossref_primary_10_1093_ofid_ofad400 crossref_primary_10_1016_j_ijid_2023_06_026 crossref_primary_10_7883_yoken_JJID_2024_184 crossref_primary_10_1093_infdis_jiad311 crossref_primary_10_3390_vaccines12050447 crossref_primary_10_15406_jhvrv_2023_10_00258 crossref_primary_10_1097_QAD_0000000000003223 crossref_primary_10_1097_COH_0000000000000789 crossref_primary_10_1016_S2352_3018_23_00266_7 crossref_primary_10_3390_vaccines9121458 crossref_primary_10_1007_s10238_022_00840_1 crossref_primary_10_1038_s41423_023_01087_w crossref_primary_10_1097_QAD_0000000000003237 crossref_primary_10_3390_vaccines10030424 crossref_primary_10_1007_s11904_021_00593_8 crossref_primary_10_1097_QAD_0000000000003597 crossref_primary_10_3390_vaccines11061087 crossref_primary_10_1108_K_03_2023_0456 crossref_primary_10_1097_QAI_0000000000003000 crossref_primary_10_3390_vaccines11020411 crossref_primary_10_1007_s10461_023_04244_4 crossref_primary_10_3390_vaccines12060663 crossref_primary_10_1097_QAD_0000000000003645 crossref_primary_10_3390_v15071449 crossref_primary_10_1111_hiv_13515 crossref_primary_10_7759_cureus_48046 crossref_primary_10_1097_QAI_0000000000003403 crossref_primary_10_1371_journal_pone_0268978 crossref_primary_10_1007_s11904_022_00618_w crossref_primary_10_3389_fimmu_2021_820126 crossref_primary_10_1016_j_clinsp_2023_100223 crossref_primary_10_2147_IDR_S353127 crossref_primary_10_1016_j_jbi_2023_104295 crossref_primary_10_3390_reports5040041 crossref_primary_10_1097_ID9_0000000000000073 crossref_primary_10_1080_21645515_2022_2151798 crossref_primary_10_1007_s10461_024_04266_6 crossref_primary_10_1007_s10461_024_04414_y crossref_primary_10_1093_infdis_jiad181 crossref_primary_10_1089_aid_2022_0079 crossref_primary_10_1016_S2352_3018_22_00097_2 crossref_primary_10_7759_cureus_38678 crossref_primary_10_1093_infdis_jiab616 crossref_primary_10_1186_s12905_023_02782_6 crossref_primary_10_1038_s41579_023_01001_1 crossref_primary_10_3389_fmed_2023_1275843 crossref_primary_10_1001_jamanetworkopen_2022_36397 crossref_primary_10_3389_fpubh_2024_1350304 crossref_primary_10_1002_jmv_28730 crossref_primary_10_1007_s10461_023_04088_y crossref_primary_10_1172_jci_insight_166848 crossref_primary_10_1097_QAD_0000000000003386 crossref_primary_10_1136_bmjopen_2022_071285 crossref_primary_10_1016_j_pmedr_2023_102448 |
ContentType | Journal Article |
Contributor | Crandall, Keith A Po-Yu Chiang, Teresa Mannon, Roslyn B Francheschini, Nora Andersen, Kathleen M Vinson, Amanda J Brown, Todd T Akelsrod, Hana French, Evan Caleb-Alexander, G Moffitt, Richard |
Contributor_xml | – sequence: 1 givenname: Richard surname: Moffitt fullname: Moffitt, Richard – sequence: 2 givenname: Hana surname: Akelsrod fullname: Akelsrod, Hana – sequence: 3 givenname: Keith A surname: Crandall fullname: Crandall, Keith A – sequence: 4 givenname: Nora surname: Francheschini fullname: Francheschini, Nora – sequence: 5 givenname: Evan surname: French fullname: French, Evan – sequence: 6 givenname: Teresa surname: Po-Yu Chiang fullname: Po-Yu Chiang, Teresa – sequence: 7 givenname: G surname: Caleb-Alexander fullname: Caleb-Alexander, G – sequence: 8 givenname: Kathleen M surname: Andersen fullname: Andersen, Kathleen M – sequence: 9 givenname: Amanda J surname: Vinson fullname: Vinson, Amanda J – sequence: 10 givenname: Todd T surname: Brown fullname: Brown, Todd T – sequence: 11 givenname: Roslyn B surname: Mannon fullname: Mannon, Roslyn B |
Copyright | Copyright © 2021 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: Copyright © 2021 Elsevier Ltd. All rights reserved. |
CorporateAuthor | National COVID Cohort Collaborative Consortium |
CorporateAuthor_xml | – sequence: 0 name: National COVID Cohort Collaborative Consortium |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1016/s2352-3018(21)00239-3 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2352-3018 |
ExternalDocumentID | 34655550 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation | National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. |
GrantInformation_xml | – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR002240 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR002733 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR002544 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR003107 – fundername: NIGMS NIH HHS sequence: 0 grantid: U54 GM104942 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR002494 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR001855 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR001998 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR001425 – fundername: NCATS NIH HHS sequence: 0 grantid: UL1 TR002553 |
GroupedDBID | -RU .1- .FO 0R~ 1P~ 4.4 457 53G AAEDT AAEDW AALRI AAMRU AAQFI AAXUO ABJNI ACGFS ADBBV AENEX AFRHN AFTJW AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ CGR CUY CVF EBS ECM EIF EJD FDB HZ~ M41 NPM O9- OD- OO. ROL Z5R |
ID | FETCH-LOGICAL-c585t-238e6bd262b405c3c9fb3cb583ee659c4924ad95e2ebb189319e0a9d7596bbf92 |
IngestDate | Sun Dec 08 01:35:14 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | Copyright © 2021 Elsevier Ltd. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c585t-238e6bd262b405c3c9fb3cb583ee659c4924ad95e2ebb189319e0a9d7596bbf92 |
OpenAccessLink | http://www.thelancet.com/article/S2352301821002393/pdf |
PMID | 34655550 |
ParticipantIDs | pubmed_primary_34655550 |
PublicationCentury | 2000 |
PublicationDate | 2021-11-01 |
PublicationDateYYYYMMDD | 2021-11-01 |
PublicationDate_xml | – month: 11 year: 2021 text: 2021-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | The lancet HIV |
PublicationTitleAlternate | Lancet HIV |
PublicationYear | 2021 |
References | 34655548 - Lancet HIV. 2021 Nov;8(11):e661-e662. doi: 10.1016/S2352-3018(21)00272-1 |
References_xml | |
SSID | ssj0001548542 |
Score | 2.5818644 |
Snippet | Evidence of whether people living with HIV are at elevated risk of adverse COVID-19 outcomes is inconclusive. We aimed to investigate this association using... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | e690 |
SubjectTerms | Adolescent Adult Aged Cohort Studies COVID-19 - epidemiology HIV Infections - epidemiology Humans Male Pandemics SARS-CoV-2 United States - epidemiology |
Title | Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34655550 |
Volume | 8 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LbxMxEICtFATqBfF-ozlwaFUZsrZ31-4NFVCoREBqg3Kr1l6vKErTiCZI7W_pf-GvdfzaXQqIx2UV2bLleD6Nx-MZm5DnsrQGJd3QmpeaiqKxtOKipkZXhhUIyFC7E93342I0EbvTfDoYfO9FLa2W-oU5-2Veyf9IFctQri5L9h8k23aKBfgb5YtflDB-_0rGvbk9aSOuRrihSyFWIdK4y350aZVfV0c-BuPDp3evaaZCtvOifcdra-bCiLBdvKzELXO1O1KY7G2Nk-fQN0Zd8hmNd-97iCh98xbrmO84Z0NMe2ttX0fkzKdcuzG26iY6rKcre5qWUX9IFZJGekUf0SyeBSTmVefdbV3eu4fVl8Oq78ZgWczn86uQV3cMTUGK6kb2dbPsI5j1FK0twiujP60AwRlx0vaG_5rhmqB8Fi_l_TY4wYsjjwZ3t8jl-fDPtZcu505Va2StlO7lkHF0FoUkdSFzwbq8sZfdsDZYthmHtE6up24u7W28jbN_k9yImxN4FUi7RQZ2fptcC8-Vnt4h533eIPIGKEtoeQPkDRJvkHiD4wYSb9tQQUcbeNog0QaeNsDyyR4k2kJTCLTBD7TBBrK2CY60u2Ty9s3-zojG1z2owS3qkqKtaAtds4Jp3DQYblSjudG55NYWuTJCMVHVKrfMap2hWZ0pO6xUXeaq0LpR7B65Mj-e2wcEDJaXVZlZNG9FZpWsCy6GCvuus0bK_CG5H6b1YBGucDlIE_7otzWPyXqH6RNytUGdYZ-iAbrUz7yYLwCSzoCv |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+between+HIV+infection+and+clinical+spectrum+of+COVID-19%3A+a+population+level+analysis+based+on+US+National+COVID+Cohort+Collaborative+%28N3C%29+data&rft.jtitle=The+lancet+HIV&rft.au=Yang%2C+Xueying&rft.au=Sun%2C+Jing&rft.au=Patel%2C+Rena+C&rft.au=Zhang%2C+Jiajia&rft.date=2021-11-01&rft.eissn=2352-3018&rft.volume=8&rft.issue=11&rft.spage=e690&rft_id=info:doi/10.1016%2Fs2352-3018%2821%2900239-3&rft_id=info%3Apmid%2F34655550&rft_id=info%3Apmid%2F34655550&rft.externalDocID=34655550 |